Gallagher Fiduciary Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
5,865
-60
-1% -$14K 0.05% 79
2026
Q1
$1.45M Buy
5,925
+36
+0.6% +$8.38K 0.06% 55
2025
Q4
$1.22M Sell
5,889
-15
-0.3% -$2.97K 0.04% 86
2025
Q3
$1.09M Sell
5,904
-140
-2% -$24K 0.04% 74
2025
Q2
$923K Buy
6,044
+277
+5% +$42.6K 0.04% 84
2025
Q1
$956K Buy
5,767
+114
+2% +$17.8K 0.03% 88
2024
Q4
$817K Buy
5,653
+946
+20% +$147K 0.16% 74
2024
Q3
$763K Buy
4,707
+537
+13% +$85.6K 0.15% 72
2024
Q2
$609K Buy
4,170
+1,105
+36% +$164K 0.14% 90
2024
Q1
$485K Buy
3,065
+718
+31% +$114K 0.02% 113
2023
Q4
$368K Sell
2,347
-230
-9% -$35.3K 0.01% 121
2023
Q3
$401K Buy
2,577
+409
+19% +$67.5K 0.04% 110
2023
Q2
$359K Sell
2,168
-189
-8% -$30.5K 0.03% 139
2023
Q1
$365K Buy
+2,357
New +$381K 0.03% 138

Other funds holding JNJ

Gallagher Fiduciary Advisors's JNJ Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its Johnson & Johnson (JNJ) stake by 1% in Q2 2026, selling an estimated $14K and leaving 5,865 shares worth $1.49M. The position accounts for 0.05% of the portfolio, ranked #79.

Gallagher Fiduciary Advisors first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gallagher Fiduciary Advisors held 5,865 shares of Johnson & Johnson worth $1.49M as of Q2 2026.
  • Gallagher Fiduciary Advisors sold 60 Johnson & Johnson shares in Q2 2026, an estimated $14K.
  • Johnson & Johnson made up 0.05% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #79 holding.
  • Gallagher Fiduciary Advisors first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.